Aarti Pharmalabs Statistics
Total Valuation
Aarti Pharmalabs has a market cap or net worth of INR 63.07 billion. The enterprise value is 64.98 billion.
Market Cap | 63.07B |
Enterprise Value | 64.98B |
Important Dates
The next estimated earnings date is Thursday, November 7, 2024.
Earnings Date | Nov 7, 2024 |
Ex-Dividend Date | Jul 31, 2024 |
Share Statistics
Aarti Pharmalabs has 90.61 million shares outstanding. The number of shares has increased by 0.04% in one year.
Shares Outstanding | 90.61M |
Shares Change (YoY) | +0.04% |
Shares Change (QoQ) | -0.02% |
Owned by Insiders (%) | 29.26% |
Owned by Institutions (%) | 20.13% |
Float | 45.15M |
Valuation Ratios
The trailing PE ratio is 28.01.
PE Ratio | 28.01 |
Forward PE | n/a |
PS Ratio | 3.24 |
PB Ratio | 3.59 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | 28.85 |
EV / Sales | 3.33 |
EV / EBITDA | 16.35 |
EV / EBIT | 20.22 |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | 16.23 |
Debt / EBITDA | 0.72 |
Debt / FCF | n/a |
Interest Coverage | 17.98 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Capital (ROIC) | 10.48% |
Revenue Per Employee | 9.31M |
Profits Per Employee | 1.08M |
Employee Count | 2,095 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +58.89% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | +58.89% |
50-Day Moving Average | 624.89 |
200-Day Moving Average | 538.99 |
Relative Strength Index (RSI) | 65.65 |
Average Volume (20 Days) | 372,089 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Aarti Pharmalabs had revenue of INR 19.50 billion and earned 2.25 billion in profits. Earnings per share was 24.85.
Revenue | 19.50B |
Gross Profit | 8.22B |
Operating Income | 3.21B |
Pretax Income | 3.10B |
Net Income | 2.25B |
EBITDA | 3.97B |
EBIT | 3.21B |
Earnings Per Share (EPS) | 24.85 |
Balance Sheet
The company has 943.17 million in cash and 2.85 billion in debt, giving a net cash position of -1.91 billion or -21.07 per share.
Cash & Cash Equivalents | 943.17M |
Total Debt | 2.85B |
Net Cash | -1.91B |
Net Cash Per Share | -21.07 |
Equity (Book Value) | 17.57B |
Book Value Per Share | 193.88 |
Working Capital | n/a |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross margin is 42.14%, with operating and profit margins of 16.49% and 11.55%.
Gross Margin | 42.14% |
Operating Margin | 16.49% |
Pretax Margin | 15.91% |
Profit Margin | 11.55% |
EBITDA Margin | 20.38% |
EBIT Margin | 16.49% |
FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 2.00, which amounts to a dividend yield of 0.29%.
Dividend Per Share | 2.00 |
Dividend Yield | 0.29% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | 1 |
Payout Ratio | n/a |
Buyback Yield | -0.04% |
Shareholder Yield | 0.25% |
Earnings Yield | 3.57% |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |